• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.

作者信息

McFarlane Samy I, Provilus Alfrede, Shin John J

机构信息

Division of Endocrinology, Diabetes and Hypertension, State University of New York Health Science Center and Kings County Hospital Center, Brooklyn, NY 11203, USA.

出版信息

J Cardiometab Syndr. 2007 Spring;2(2):149-50. doi: 10.1111/j.1559-4564.2007.06663.x.

DOI:10.1111/j.1559-4564.2007.06663.x
PMID:17684471
Abstract
摘要

相似文献

1
Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.肾素-血管紧张素-醛固酮系统（RAAS）抑制与过氧化物酶体增殖物激活受体γ（PPAR-γ）激动在糖尿病预防中的作用：雷米普利与罗格列酮降低糖尿病风险评估（DREAM）试验
J Cardiometab Syndr. 2007 Spring;2(2):149-50. doi: 10.1111/j.1559-4564.2007.06663.x.
2
[DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease].[DREAM研究：使用雷米普利和/或罗格列酮预防血糖异常但无心血管疾病患者的2型糖尿病]
Rev Med Liege. 2006 Oct;61(10):728-32.
3
[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].雷米普利和罗格列酮对糖尿病发病率的影响：DREAM研究（雷米普利和罗格列酮药物降低糖尿病评估）
Internist (Berl). 2007 Oct;48(10):1173-6. doi: 10.1007/s00108-007-1932-8.
4
[Three studies in type 2 diabetes: DREAM the wash-out results].
Ann Endocrinol (Paris). 2007 Jun;68 Suppl 1:36-8. doi: 10.1016/s0003-4266(07)80009-6.
5
Diabetes prevention: still no effective drugs.糖尿病预防：仍无有效药物。
Prescrire Int. 2007 Dec;16(92):258.
6
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.雷米普利和罗格列酮对糖耐量受损或空腹血糖受损人群心血管和肾脏结局的影响：雷米普利和罗格列酮药物降低糖尿病风险评估（DREAM）试验结果
Diabetes Care. 2008 May;31(5):1007-14. doi: 10.2337/dc07-1868. Epub 2008 Feb 11.
7
Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.重要试验：罗格列酮、雷米普利与2型糖尿病的预防
Ann Intern Med. 2007 Mar 20;146(6):461-3. doi: 10.7326/0003-4819-146-6-200703200-00015.
8
[Experiences of the DREAM trial].[DREAM试验的经验]
Orv Hetil. 2006 Dec 31;147(52):2523-6.
9
[The DREAM of diabetes prevention].[糖尿病预防之梦]
Rev Med Suisse. 2007 Jan 17;3(94):132, 134-6.
10
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.种族对糖尿病发病率和预防的影响：雷米普利和罗格列酮药物降低糖尿病风险评估（DREAM）试验的结果。
Diabet Med. 2010 Nov;27(11):1226-32. doi: 10.1111/j.1464-5491.2010.03064.x.

引用本文的文献

1
Management of arterial hypertension in obese patients.肥胖患者动脉高血压的管理。
Curr Hypertens Rep. 2007 Dec;9(6):491-7. doi: 10.1007/s11906-007-0090-7.